C. Richard Schlegel

Dr. Richard Schlegel’s laboratory at Georgetown developed the technology for the human papillomavirus (HPV) vaccine, for which the dominant patent for the vaccine technology was awarded by the U.S. Patent Office in 2005. The U.S. Food and Drug Administration approved the HPV vaccine for use in June 2006.